1. Home
  2. OMCL vs PLSE Comparison

OMCL vs PLSE Comparison

Compare OMCL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCL
  • PLSE
  • Stock Information
  • Founded
  • OMCL 1992
  • PLSE 2014
  • Country
  • OMCL United States
  • PLSE United States
  • Employees
  • OMCL N/A
  • PLSE N/A
  • Industry
  • OMCL Computer Manufacturing
  • PLSE Medical/Dental Instruments
  • Sector
  • OMCL Technology
  • PLSE Health Care
  • Exchange
  • OMCL Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • OMCL 1.5B
  • PLSE 1.3B
  • IPO Year
  • OMCL 2001
  • PLSE 2016
  • Fundamental
  • Price
  • OMCL $25.78
  • PLSE $17.07
  • Analyst Decision
  • OMCL Buy
  • PLSE
  • Analyst Count
  • OMCL 6
  • PLSE 0
  • Target Price
  • OMCL $45.83
  • PLSE N/A
  • AVG Volume (30 Days)
  • OMCL 725.6K
  • PLSE 159.2K
  • Earning Date
  • OMCL 05-06-2025
  • PLSE 05-08-2025
  • Dividend Yield
  • OMCL N/A
  • PLSE N/A
  • EPS Growth
  • OMCL N/A
  • PLSE N/A
  • EPS
  • OMCL 0.45
  • PLSE N/A
  • Revenue
  • OMCL $1,135,755,000.00
  • PLSE N/A
  • Revenue This Year
  • OMCL $3.75
  • PLSE N/A
  • Revenue Next Year
  • OMCL $4.42
  • PLSE N/A
  • P/E Ratio
  • OMCL $57.25
  • PLSE N/A
  • Revenue Growth
  • OMCL 3.00
  • PLSE N/A
  • 52 Week Low
  • OMCL $22.66
  • PLSE $6.66
  • 52 Week High
  • OMCL $55.75
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • OMCL 28.65
  • PLSE 50.34
  • Support Level
  • OMCL $22.66
  • PLSE $15.92
  • Resistance Level
  • OMCL $32.18
  • PLSE $17.54
  • Average True Range (ATR)
  • OMCL 1.17
  • PLSE 0.93
  • MACD
  • OMCL -0.46
  • PLSE -0.08
  • Stochastic Oscillator
  • OMCL 32.77
  • PLSE 32.58

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: